Mature Outcomes from the Phase I Trial of Orca-T and Allogeneic CD19/CD22 CAR-T cells for Adults with High-Risk B-ALL

Transplantation and Cellular Therapy 2026

View at publisher
Authors: Alfonso Molina, Parveen Shiraz, Alyssa M. Kanegai, Ayesha Fraser, Diana Kordek, Caroline Wagner, Lindsay Danley, Arvind Ramakrishnan, Hossein Daghagh, Yingwen. Huang, Gaurav Dhapola, Aman Siddiqui
+23 more Sally Arai, Sushma Bharadwaj, Saurabh Dahiya, Hany Elmariah, Matthew Frank, Hitomi Hosoya, Vanessa Elaine Kennedy, Laura Johnston, Everett H. Meyer, Lekha Mikkilineni, Robert Lowsky, Robert S. Negrin, Andrew R. Rezvani, Judith A. Shizuru, Surbhi Sidana, Wen-Kai Weng, Catherine A. McIntyre, Bita Sahaf, Steven A. Feldman, Crystal L. Mackall, David B. Miklos, Melody Smith, Lori S. Muffly
DOI: 10.1016/j.jtct.2025.12.047
Cited by: 1

Fields of Study & Subjects

CAR-T cell therapy research Acute Lymphoblastic Leukemia research Hematopoietic Stem Cell Transplantation

Publication details

Journal / source
Transplantation and Cellular Therapy
Publisher
Elsevier BV
Volume
32
Issue
2
Pages
S27–S27
Publication date
1 February 2026
Language
EN